Pharmacy Blog

Evidence uncovered of illegal drug use at events
if people only knew

By Kaustubh Kulkarni and Tony Munroe MUMBAI (Reuters) – Drugmaker Cipla (CIPL.NS), long a thorn in the side of big pharma, is looking at cutting the prices of more cancer drugs after it slashed the prices …
blog updated each day, visit us again

COPENHAGEN (Reuters) – Two hemophilia drugs being developed by Danish drugmaker Novo Nordisk could hold blockbuster potential though sales of its only hemophilia drug on the market will be flat this year, its chief science officer said. Novo Nordisk aims for a hemophilia drug candidate, Vatreptacog, to replace at least part of the 8.3 billion crowns ($1.48 billion) in annual sales of its only …
so interesting

New illicit drugs are appearing on the European Union market at a rate of nearly one a week, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) said on Thursday.
never miss a day, thanks for the blog

LONDON (Reuters) – During an informative and entertaining address to an anti-doping conference last month, German researcher Mario Thevis referred to "80, 90, 100" new performance-enhancing drugs for which no tests yet exist. "They act like EPO (erythropietin) but they are structurally different and that means the current EPO tests will not pick them up," he told delegates to the conference in …
so interesting

Two Merck drugs for treating male baldness and enlarged prostate will now carry extended labels to add more possible sexual side effects, US regulators said.
more to read in our archives

NEW YORK, April 11, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Orphan Drugs in Asia 2012 http://www.reportlinker.com/p0510901/Orphan-Drugs-in-Asia-2012.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_MedicationHistorically, …
so interesting

LONDON (Reuters) – Stamping out trade in counterfeit drugs like Roche's Avastin is an uphill fight for regulators, whose task is complicated by the presence of thousands of small wholesalers across Europe. In Britain alone – the transit point for a second fake batch of the cancer drug uncovered in the U.S. market – there are around 1,800 licensed wholesalers, according to the Medicines and …
maybe this will change things

MONDAY, April 2 (HealthDay News) — First-time users of osteoporosis drugs called oral bisphosphonates may be at increased risk for serious inflammatory eye disease, a new study contends.
does anyone know when this will take effect

WASHINGTON (Reuters) – Health regulators are asking for advice on whether, and when, heart safety studies should be required for new obesity drugs, possibly adding a new hurdle on their path to approval. An advisory panel to the Food and Drug Administration will discuss this week whether regulators should mandate such trials before the drugs can be marketed in the United States. …
more to read in our archives